ALCER Share Price

Open 2.00 Change Price %
High 2.00 1 Day 0.00 0.00
Low 2.00 1 Week 0.00 0.00
Close 2.00 1 Month 0.00 0.00
Volume 20 1 Year 0.00 0.00
52 Week High 44.95
52 Week Low 23.95
ALCER Important Levels
Resistance 2 2.00
Resistance 1 2.00
Pivot 2.00
Support 1 2.00
Support 2 2.00
EPA France Most Active Stocks
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
GSZ 17.56 3.97%
GSZ 17.56 3.97%
GSZ 17.56 3.97%
BRS 12.00 0.00%
BRS 12.00 0.00%
More..
EPA France Top Gainers Stocks
CFI 2.46 83.58%
CFI 2.46 83.58%
CFI 2.46 83.58%
CFI 2.46 83.58%
APAM 33.78 15.72%
APAM 33.78 15.72%
DEXB 17.47 13.89%
DEXB 17.47 13.89%
MT 4.53 12.97%
MT 4.53 12.97%
More..
EPA France Top Losers Stocks
MLERO 0.37 -17.78%
MLLEM 0.50 -15.25%
OXI 0.08 -11.11%
OXI 0.08 -11.11%
ALENT 0.78 -10.34%
HDP 1.80 -9.09%
HBW 0.15 -6.25%
SFCA 2.09 -5.86%
JXR 0.81 -5.81%
ALMGI 2.17 -5.65%
More..

Cerep SA (EPA: ALCER)

ALCER Technical Analysis 5
As on 30th Jul 2014 ALCER Share Price closed @ 2.00 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.07 & Strong Sell for SHORT-TERM with Stoploss of 2.05 we also expect STOCK to react on Following IMPORTANT LEVELS.
ALCER Target for August
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
ALCER Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.cerep.fr
ALCER Address
ALCER
Le bois l'Ev
Celle l'Evescault, 86600
France
Phone: 33 5 49 89 30 00
Fax: 33 5 49 43 21 70
ALCER Latest News
Interactive Technical Analysis Chart Cerep SA ( ALCER EPA France )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Cerep SA
ALCER Business Profile
Cerep SA provides in vitro pharmacology, in vitro ADME-Tox, and in vivo PK services to pharmaceutical and biotechnology companies worldwide. The company offers various research services, including compound management, high-throughput screening, in vitro safety profiling, lead optimization profiling, in vitro ADME profiling, and in vivo PK; and custom research services comprising assay development, profile design, and data interpretation, as well as scientist-to-scientist communications. Its platforms cover a range of target classes, such as GPCRs, kinases, nuclear receptors, and employing methods; and assay types, including radioligand binding assays, calcium mobilization and cAMP measurement, transporter/uptake assays, bioluminescent, and other fluorescent-based assays. The company also provides BioPrint profiles and services, a homogenous pharmacology and ADME database comprising data sets, such as chemical descriptors, compound descriptors, and in vivo effects of drugs, which offer a resource for supporting decision making in drug discovery. Cerep SA was founded in 1989 and is headquartered in Celle l'Evescault, France. As of February 27, 2013, Cerep SA operates as a subsidiary of Eurofins Scientific SA.